Lack of evidence for an association between the frequency of mutants or translocations in circulating lymphocytes and exposure to radon gas in the home

Radiation Research

Volumn 145, Issue 1, 1996, Pages 61-69

  Cole, Jane ^a   Green, Michael H L ^a   Bridges, Bryn A ^a   Waugh, Alastair P W ^a   Beare, David M ^a   Henshaw, Denis ^b   Last, Rex ^c   Liu, Yafei ^d,f   Cortopassi, Gino ^e  

^a UNIVERSITY OF SUSSEX   (United Kingdom)

^b UNIVERSITY OF BRISTOL   (United Kingdom)

^c Vine Surgery   (United Kingdom)

^d UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^e UNIVERSITY OF CALIFORNIA   (United States)

^f STANFORD UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

RADON;

ARTICLE; CHROMOSOME TRANSLOCATION 14; CHROMOSOME TRANSLOCATION 18; DOSIMETRY; GENE MUTATION; HOME; HUMAN; LEUKEMIA; LYMPHOMA; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RADIATION EXPOSURE; RURAL AREA;

ADULT; AGED; ANALYSIS OF VARIANCE; CHROMOSOMES, HUMAN, PAIR 14; CHROMOSOMES, HUMAN, PAIR 18; DOSE-RESPONSE RELATIONSHIP, RADIATION; ENGLAND; ENVIRONMENTAL EXPOSURE; GENE FREQUENCY; GREAT BRITAIN; HOUSING; HUMANS; HYPOXANTHINE PHOSPHORIBOSYLTRANSFERASE; LYMPHOCYTES; MIDDLE AGED; MUTATION; POLYMERASE CHAIN REACTION; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-BCL-2; PROTO-ONCOGENES; RADON; SMOKING; TRANSLOCATION, GENETIC;

EID: 0030042133     PISSN: 00337587     EISSN: None     Source Type: Journal    
DOI: 10.2307/3579196     Document Type: Article

References (52)

1. D. L. Henshaw, J. Perryman, P. A. Keitch, J. E. Allen and G. C. Camplin, Radon in domestic water supplies in the UK. Radiat. Prot. Dostm. 46, 285-289 (1993).
2. B. A. Brill, D. V. Becker, K. Donahoe, S. J. Goldsmith, B. Greenspan, K. Kase, H. Royal, E. B. Silberstein and E. W. Webster, Radon update: facts concerning environmental radon: levels, mitigation strategies, dosimetry, effects and guidelines, J. Nucl. Med. 35, 368-385 (1994).
3. NCRP, Evaluation of Occupational and Environmental Exposures to Radon and Radon Daughters in the United States. Report 78, National Council on Radiation Protection and Measurements, Bethesda, MD. 1984.
4. National Research Council, Committee on the Biological Effects of Ionizing Radiation, Health Risks of Radon and Other Internally Deposited Alpha-Emitters (BEIR IV). National Academy Press, Washington, DC, 1988.
5. IARC. Man-made Mineral Fibres and Radon. International Agency for Research on Cancer, Lyon, 1988.
6. F. T. Cross, Invited commentary: residential radon risks from the perspective of experimental animal studies. Am. J. Epidemiol. 140, 333-339 (1994).
7. K. H. Vahakangas, J. M. Samet, R. A. Metcalf, J. A. Welsh, W. P. Bennett, D. P. Lane and C. C. Harris, Mutations of p53 and ras genes in radon-associated lung cancer from uranium miners. Lancet 339, 576-580 (1992).
8. J. A. Taylor, M. A. Watson, T. R. Devereux, R. Y. Michels, G. Saccomanno and M. Anderson. p53 mutation hotspot in radon-associated lung cancer. Lancet 343. 86-87 (1994).
9. T. K. Hei, J. Bedford and C. A. Waldren, p53 mutation hotspot in radon-associated lung cancer. Lancet 343, 1158-1159 (1994). [Letter to Editor]
10. J. Peto and S. Darby, Luns cancer: Radon risk reassessed. Nature 368, 97-98 (1994). [News and Views]
11. J. H. Lubin, Invited commentary: lung cancer and exposure to residential radon. Am. J. Epidemiol, 140, 323-332 (1994).
12. A. Schmidt, EPA's approach to radon risk assessment. J. Radioanal. Nucl. Chem. 161, 283-291 (1992).
13. M. W. Jones and E. M. Dron, Domestic radon reduction strategy in the UK. Radiat Prot. Dosim. 45 (Suppl.), 763-766 (1992).
14. S. H. Moolgavkar, E. G. Luebeck, D. Drewski and J. M. Zielinski, Radon, cigarette smoke, and lung cancer: a re-analysis of the Colorado Plateau uranium miners' data. Epidemiology 4, 204-217 (1993).
15. K. Steenland, Age specific interactions between smoking and radon among United States uranium miners. Occup. Environ. Med. 51, 192-194 (1994).
16. D. Thomas, J. Pogoda, B. Langholz and W. Mack, Temporal modifiers of the radon-smoking interaction. Health Phys. 66, 257-262 (1994).
17. N. P. Lucie, Radon exposure and leukaemia. Lancet II, 99-100 (1989). [Letter to Editors]
18. F. E. Alexander, P. A. McKinney and R. A. Cartwright, Radon and leukaemia. Lancei 335, 1336-1337 (1990). [Letter to Editors]
19. D. Henshaw, J. P. Eatough and R. B. Richardson, Radon: a causative factor in the induction of myeloid leukaemia and other cancers in adults and children? Lancet 335, 1008-1012 (1990).
20. D. L. Henshaw and J. P. Eatough, Radon: possible links with leukaemia and other non-lung cancers. In 1st International Conference of the Society of Radiological Protection on Reassessment of Radiation Risk, Keil, FRG (E. Lengfelder and H. Wendhausen, Eds.). MMV Medicin Verlag Gmbh, Munchen, 1993.
21. A. K. M. Haque and A. E. Kirk, Environmental radon and cancer risk. Radiat. Prot. Dosim. 45, 639-642 (1992).
22. J. P. Eatough and D. L. Henshaw, Radon dose to the skin and the possible induction of skin cancers. Radiat. Prot. Dosim. 39, 33-37 (1991).
23. M. Wakefield and J. A. Kohler, Indoor radon and childhood cancer. Lancet 338, 1537-1538 (1991). [Letter to Editors]
24. S. P. Wolff and G. Stern, Geographical associations between radon and cancer: Is domestic radon level a marker of socioeconomic status? J. Radiol. Prot. 11, 225-230 (1991).
25. L. Tomasek, S. C. Darby, A. J. Swerdlow, V. Placek and E. Kunz, Radon exposure and cancers other than lung cancer among uranium miners in West Bohemia. Lancet 341, 919-923 (1993).
26. N. K. Foreman, R. Thorne, P. J. Berry, A. Oakhill and M. G. Mott. Childhood malignancies in the South-West region of England, 1976-1985. Med. Pediatr. Oncol. 23, 14-19 (1994).
27. A. V. Carrano and A. T. Natarajan, Considerations for population monitoring using cytogenetic techniques. Mutat. Res. 204, 379-406 (1988).
28. J. Cole and T. R. Skopek, Somatic mutant frequency, mutation rates and mulational spectra in the human population in vivo. Mutat. Res. 304, 33-105 (1994).
29. B. A. Bridges, J. Cole, C. F. Arlett, M. H. L. Green, A. P. W. Waugh, D. Beare, D. L. Henshaw and R. D. Last, Possible association between mutant frequency in peripheral lymphocytes and domestic radon concentrations. Lancet 337, 1187-1189 (1991).
30. M. Bauchinger, E. Schmid, H. Braselmann and U. Kulka, Chromosome aberrations in peripheral lymphocytes from occupants of houses with elevated indoor radon concentrations. Mutat. Res. 310, 135-142 (1994).
31. H. J. Albering, G. J. Hageman, J. C. S. Kleinjans, J. J. M. Engelen, L. Koulischer and C. Herens, Indoor radon exposure and cytogenetic damage. Lancet 340, 739 (1992). [Letter to Editors]
32. H. J. Albering, J. J. Engelen, L. Koulischer, I. J. Welle and J. C. Kleinjans. Indoor radon, an extrapulmonary genetic risk? Lancet 344. 750-751 (1994). [Letter to Editors]
33. K. T. Kelsey, A. Memisoglu, A. Frenkel and H. L. Liber. Human lymphocytes exposed to low doses of X-rays are less susceptible to radiation-induced mutagenesis. Mutat. Res. 263, 197-201 (1991).
34. D. R. Robinson, K. Goodall, R. J. Albertini, J. P. O'Neill, B. Finett. M. Sala-Trepat, A. D. Tates, E. Moustacchi, D. Beare, M. H. L. Green and J. Cole, An analysis of in vivo hprt mutant frequency in circulating T-lymphocytes in the normal human population: a comparison of four datasets. Mutat. Res. 313, 227-247 (1994).
35. Y. Liu, A. M. Hernandez, D. Shibata and G. A. Cortopassi, BCL2 translocation frequency rises with age in humans. Proc. Natl. Acad. Sci. USA 91, 8910-8914 (1994).
36. K. D. Cliff, J. C. H. Miles and M. C. O'Riordan, Validation Scheme for Laboratories Making Measurements of Radon in Dwellings. National Radiological Protection Board, Didcot. 1991.
37. B. A. Bridges, J. Cole and M. H. L. Green, Smoking, leukemia and lymphocyte mutations. Leukemia 3, 846 (1989). [Letter to Editor]
38. D. A. Bell, Y. Liu and G. A. Cortopassi, Occurrence of bcl-2 oncogene translocation with increased frequency in the peripheral blood of heavy smokers. J. Natl. Cancer Inst. 87, 223-224 (1995).
39. J. Cole, M. H. L. Green, S. E. James, L. Henderson and H. Cole, Human population monitoring: a further assessment of factors influencing measurements of thioguanine-resistant mutant frequency in circulating T-lymphocytes. Mutat. Res. 204, 493-507 (1988).
40. J. Sambrook, E. F. Fritsch and T. E. Maniatis, Molecular Cloning: a Laboratory Manual, 2nd ed. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY. 1989.
41. J. Cole, C. F. Arlett, M. H. L. Green, D. Holdsworth, E. J. Tawn and B. A. Bridges, Mutant frequencies in workers at the Sellafield installation. Health Phys. 68, 388-393 (1995).
42. J. H. Lubin, J. D. Boice, Jr., C. Edling, R. W. Hornung, G. Howe, E. Kunz, R. A. Kusiak, H. I. Morrison, E. P. Radford, J. M. Samet, M. Tirmarche, A. Woodward, S. X. Yao and D. A. Pierce, Lung Cancer and Radon: A Joint Analysis of 11 Underground Miners Studies. Publication No. 94-3644, U.S. National Institutes of Health. Bethesda, MD, 1994.
43. J. Porstendôrfer and T. Mercer, Influence of electric charge and humidity upon the diffusion coefficient of radon decay products. Health Phys. 37, 191-199 (1979).
44. J. B. Klotz, J. B. Schoenberg and H. B. Wilcox, Relationship among short- and long-term radon measurements within dwellings: influence of radon concentrations. Health Phys. 65, 367-374 (1993).
45. M. H. L. Green, J. P. O'Neill and J. Cole. Suggestions concerning the relationship between mutant frequency and mutation rate at the hprt locus in human peripheral T-lymphocytes. Mutat. Res. 334, 323-339 (1995).
46. J. A. Nicklas, J. P. O'Neill, L. M. Sullivan, T. C. Hunter, M. Allegretta, B. F. Chastenay, B. L. Libbus and R. J. Albertini, Molecular analyses of in vivo hprt mutations in human T-lymphocytes II: Demonstration of a clonal amplification of hprt mutant T-lymphocytes in vivo. Environ. Mol. Mutagen. 12, 271-284 (1988).
47. J. P. O'Neill, J. A. Nicklas, T. C. Hunter, O. B. Batson, M. Allegretta, M. T. Falta, R. F. Branda and R. J. Albertini, The effect of T-lymphocyte "clonality" on the calculated human hprt mutation frequency occurring in vivo in humans. Mutat Res , 313, 215-225 (1994).
48. M. M. Ammenheuser, J. B. J. Ward, E. B. Whorton, J. M. Killian and M. S. Legator, Elevated frequencies of 6-thioguanine resistant lymphocytes in multiple sclerosis patients treated with cyclophosphamide: A prospective study. Mutat. Res. 204, 509-520 (1988).
49. M. N. Ammenheuser, W. W. Au, E. B. J. Whorton, J. A. Belli and J. B. J. Ward, Comparison of Hprt variant frequencies and chromosome aberration frequencies in lymphocytes from radiotherapy and chemotherapy patients: A prospective study. Environ. Mol. Mutagen. 18, 126-135 (1991).
50. M. Sala-Trepat, J. Cole, M. H. L. Green, O. Rigaud, J. R. Vilcoq and E. Moustacchi, Genotoxic effects of radiotherapy and chemotherapy on the circulating lymphocytes of breast cancer patients. III: Measurement of mutant frequency to 6-thioguanine resistance. Mutagenesis 5, 593-598 (1990).
51. A. A. Freitas and B. B. Rocha, Lymphocyte lifespans: Homeostasis. selection and competition. Immunol. Today 14, 25-29 (1993).
52. J. S. Neuberger, C. F. Lynch, B. C. Kross, R. W. Field and R. F. Woolson, Residential radon exposure and lung cancer: evidence of an urban factor in Iowa. Health Phys. 66, 263-269 (1994).